Comparative study of preemptive Ketorolac and Tetracaine eye drops on the need for sedatives and analgesics during and after cataract surgery

authors:

avatar Mojgan Mortazavi , * , avatar Darioush Moradi Farsani ORCID , ** , avatar Arian Amirkhosravi , avatar Kamran Montazeri

Corresponding Authors:
Koomesh: Vol.24, issue 3; 306-312
published online: August 01, 2022
article type: Research Article
received: May 02, 2021
accepted: October 01, 2021

how to cite: Mortazavi M, Moradi Farsani D, Amirkhosravi A, Montazeri K. Comparative study of preemptive Ketorolac and Tetracaine eye drops on the need for sedatives and analgesics during and after cataract surgery. koomesh. 2022;24(3):e152739. 

Abstract

Introduction: Tetracaine drop is commonly used in ophthalmic surgeries. Ketorolac drop is an anti-inflammatory drug that has been used in some surgical procedures. The present study compared the effect of Ketorolac and Tetracaine eye drops on the need for sedative and analgesic medications during and after cataract surgery. Materials and Methods: In this clinical trial study, 86 patients undergoing cataract surgery were distributed into two equal groups as receiving Tetracaine 0.5% or Ketorolac 0.5% eye drops, one drop every 10 min from 30 min before surgery. Postoperative pain, rescue doses of the sedative drugs, hemodynamic variables, nausea and vomiting, hypoxia, and respiratory depression were evaluated in both groups. Results: Significant differences were not found between the two groups based on hemodynamic variables during surgery and recovery period, postoperative pain up to 24 hours, postoperative nausea and vomiting, and complication such as hypoxia and respiratory distress (P>0.05). Notably, no significant differences were found between the two groups based on midazolam and propofol rescue doses (P>0.05). Conclusion: There were no significant differences between Tetracaine and Ketorolac eye drops regarding the sedation and analgesia requirements and hemodynamic parameters during and after the cataract operation.

References

  • 1.

    Dadac Z, Borazan M, Acr N. Pain perception in phacoemulsification with topical anesthesia and evaluation of factors related with pain. Turk J Ophthalmol 2016; 46: 151-155.

  • 2.

    Allen D, Vasavada A. Cataract and surgery for cataract. BMJ 2006; 333: 128-132.

  • 3.

    Porela-Tiihonen S, Kaarniranta K, Kokki M, Purhonen S, Kokki H. A prospective study on postoperative pain after cataract surgery. Clin Ophthalmol (Auckland, NZ) 2013; 7: 1429.

  • 4.

    Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1593-1601.

  • 5.

    West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the US Medicare population increased between 1994 and 2001. Ophthalmology 2005; 112: 1388-1394.

  • 6.

    Cetinkaya S, Dadaci Z, Aksoy H, Acir NO, Yener HI, Kadioglu E. Toxic anterior-segment syndrome (TASS). Clin Ophthalmol (Auckland, NZ) 2014; 8: 2065.

  • 7.

    Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and metaanalysis. Acta Ophthalmol 2015; 93: 303-317.

  • 8.

    Assam JH, Bernhisel A, Lin A. Intraoperative and postoperative pain in cataract surgery. Surv Ophthalmol 2017; 63: 75-85.

  • 9.

    Borazan M, Karalezli A, Akova Y, Algan C, Oto S. Comparative clinical trial of topical anaesthetic agents for cataract surgery with phacoemulsification: lidocaine 2% drops, levobupivacaine 0.75% drops, and ropivacaine 1% drops. Eye 2008; 22: 425.

  • 10.

    Apil A, Kartal B, Ekinci M, Cagatay HH, Keles S, Ceylan E, et al. Topical anesthesia for cataract surgery: the patients' perspective. Pain Res Treat 2014; 2014: 827659.

  • 11.

    Donnenfeld E, Shojaei R. Effect of intracameral phenylephrine and ketorolac 1.0%/0.3% on intraoperative pain and opioid use during cataract surgery. Clin Ophthalmol 2019; 13: 2143-2150.

  • 12.

    Crandall AS, Zabriskie NA, Patel BC, Burns TA, Mamalis N, Malmquist-Carter LA, et al. A comparison of patient comfort during cataract surgery with topical anesthesia versus topical anesthesia and intracameral lidocaine1. Ophthalmology 1999; 106: 60-66.

  • 13.

    Lofoco G, Ciucci F, Bardocci A, Quercioli P, De Gaetano C, Ghirelli G, et al. Efficacy of topical plus intracameral anesthesia for cataract surgery in high myopia: randomized controlled trial. J Cataract Refract Surg 2008; 34: 1664-1668.

  • 14.

    Rahimi Varposhti M, Moradi Farsani D, Ali Kiaei B, Nazem Roaya B, Moosavi H. Effects of preemptive eye drops ketorolac plus tetracaine on pain intensity and hemodynamic changes in cataract surgery. J Arak Univ Med Sci 2017; 20: 68-79. (Persian).

  • 15.

    Mohammadpour M, Heidari Z and Molani R. Comparison between diclofenac and ketorolac ophthalmic drops for pain management after photorefractive keratectomy: a randomized clinical study. Eye Contact Lens 2019; 45: 137-140.

  • 16.

    Saryazdi H, Aghadavoudi O, Moradi D, Hamedani A. Comparison the efficacy of pre-emptive oral celecoxib with acetaminophen in controlling post-operative pain and nausea after lower limb surgery under general anesthesia. J Cell Mol Anesthesia 2016; 1: 62-68.

  • 17.

    Cepeda MS, Carr DB, Miranda N, Diaz A, Silva C, Morales O. Comparison of morphine, ketorolac, and their combination for postoperative pain: results from a large, randomized, double-blind trial. J Am Soc Anesthesiol 2005; 103: 1225-1232.

  • 18.

    Brilakis HS, Deutsch TA. Topical tetracaine with bandage soft contact lens pain control after photorefractive keratectomy. J Refract Surg 2000; 16: 444-447.

  • 19.

    Shah NV, Vaddavalli PK, Chow JH, Roman JS, Shi W, Yoo SH. Prospective, double-masked, randomized trial comparing lidocaine gel to tetracaine drops in femtosecond laser-assisted LASIK. J Refract Surg 2012; 28: 671-672.

  • 20.

    Razmju H, Khalilian A, Peyman A, Abtahi SH, Abtahi M-A, Akbari M, et al. Preoperative topical diclofenac and ketorolac in prevention of pain and discomfort following photorefractive keratectomy: a randomized double-masked placebo-controlled clinical trial. Int J Prev Med 2012; 3: S199.

  • 21.

    Price MO, Price FW. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin 2004; 20: 2015-2019.

  • 22.

    Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 2001; 108: 331-337.

  • 23.

    Moradi Farsani D, Naghibi Kh,Alikiaei B, Mashayekhi Z. Comparison of the effects of intravenous phenylephrine and ephedrine in treatment of hypotension after spinal anesthesia in orthopedic surgery. J Babol Univ Med Sci 2016; 18: 21-27. (Persian).

  • 24.

    Adinehmehr L, Shetabi H, Moradi Farsani D, Salehi A, Noorbakhsh M. Comparison of the sedation quality of etomidate, propofol, and midazolam in combination with fentanyl during phacoemulsification cataract surgery: a double-blind, randomized, controlled, clinical trial. Anesth Pain Med 2019; 9: e87415.

  • 25.

    Moradi-Farsani D, Azamian-Jazi Z, Heydari SM, NazemroayaB. The effect of subcutaneous injection of metoclopramide, pethidine, and ketamine on postoperative pain after inguinal hernia repair under general anesthesia. J Isfahan Med Sch 2020; 38: 252-259. (Persian).##.